News

The CCHIT is an ONC Authorized Testing and Certification Body (ONC-ATCB). The 2011/2012 criteria support the stage 1 meaningful use measures required to qualify eligible healthcare providers and

RemedyMD said ComprehensiveBMT solves key challenges of hematopoietic stem cell transplant (HSCT) research such as reporting data obtained from patients and donors (various disparate sources) after aggregating, linking,

As per the alliance, HORIBA’s full array of instruments and systems for applications ranging from automotive R&D, process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing and metrology,

NP-1 contains the FDA-approved drugs amitriptyline and ketamine to relieve pain from various peripheral neuropathies in chemotherapy-induced peripheral neuropathy (CPN). The Community Clinical Oncology Program funded, multi-center, double-blind,

L-DOS47, Helix’s first therapeutic immunoconjugate drug candidate under development based upon its novel DOS47 platform technology, is designed to modify the microenvironmental conditions of cancer cells so that

REYATAZ is a protease inhibitor that has been studied in both treatment-naïve and treatment-experienced HIV-1-infected patients and is administered once daily as part of combination HIV therapy. Since

The methylnaltrexone license includes intellectual property from the University of Chicago, Progenics Pharmaceuticals and Wyeth Pharmaceuticals, including patents and applications with expiration dates that will range from 2017

Tamiflu was invented by Gilead Sciences and licensed to F Hoffmann-La Roche in 1996. In the notice letter, Natco requested permission to manufacture and market a generic version

The US Patent No 7,865,534, titled ‘System, Method and Apparatus for Assembling and Mining Life Science Data,’ describes an in silico-based data storage system that allows scientists to